Wei Ding

2.2k citations
65 papers · 1.6k · h-index 23

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Retinoids in leukemia and cellular processes
    • Ubiquitin and proteasome pathways
    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation
    • Cell death mechanisms and regulation

Papers in

Wei Ding

64 papers receiving 1.6k citations

Peers

Wei Ding
Comparison fields: 5 of 97
  • Hematology 186
  • Molecular Biology 847
  • Cancer Research 149
  • Oncology 254
  • Pulmonary and Respiratory Medicine 278
Replace Jun-ichiro Miyagawa with:
Jun-ichiro Miyagawa Japan
Thea Kalebic United States
Yoshinobu Hoshii Japan
Geoffrey I. Johnston United Kingdom
Katya J. Henley Australia
Gautam Shrikhande United States
Violeta Rus United States
Wen‐Chiuan Tsai Taiwan
Davide Soldini Switzerland
Jun Zhan China
Wei Ding relative to Jun-ichiro Miyagawa Japan Jun-ichiro Miyagawa's profile →
Citations per field
00.5×10×
Jun-ichiro Miyagawa · 1×
Citations per year

Countries citing papers authored by Wei Ding

Since Specialization
Citations

This map shows the geographic impact of Wei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ding more than expected).

Fields of papers citing papers by Wei Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ding. The network helps show where Wei Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Ding Line = papers co-authored together Wei Ding links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018149
2 2005130
3 1998109
4 200293
5 200285
6 200477
7 201573
8 199965
9 200445
10 201843
11 200941
12 201440
13 200639
14 200638
15 201537
16 201436
17 201835
18 200534
19 201030
20 200830

About Wei Ding

Wei Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Hematology, having authored 65 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Retinoids in leukemia and cellular processes (5 papers), Cell death mechanisms and regulation (5 papers), Acute Myeloid Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Ubiquitin and proteasome pathways (3 papers), Breast Cancer Treatment Studies (3 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Hematology (186 citations), Molecular Biology (847 citations), Cancer Research (149 citations), Oncology (254 citations) and Pulmonary and Respiratory Medicine (278 citations). Wei Ding has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Robert E. Gallagher, Weiping Zhang, Hong‐Tian Yao, Jing Zhao, Raymond P. Warrell, Kun Xiong, Lei Shang, Jianying Zhou, Cynthia Schultz and Soon H. Kim. Their work appears in journals such as PLoS ONE, Blood, Modern Pathology, Applied immunohistochemistry & molecular morphology and BMC Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact